tenilsetam has been researched along with Alzheimer Disease in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dhananjayan, K; Gunawardena, D; Gyengesi, E; Liang, H; Millington, C; Münch, G; Niedermayer, G; Sirijovski, D; Sonego, S; Venigalla, M | 1 |
| Münch, G; Palm, D; Riederer, P; Schindler, U; Schinzel, R; Schraven, E; Taneli, Y | 1 |
| Cunningham, AM; Hipkiss, AR; Mayer, S; Michaelis, J; Müller, R; Münch, G; Neumann, A; Riederer, P; Schinzel, R | 1 |
| Retz, W; Riederer, P; Rösler, M; Thome, J | 1 |
1 review(s) available for tenilsetam and Alzheimer Disease
| Article | Year |
|---|---|
Free radicals in Alzheimer's dementia: currently available therapeutic strategies.
Topics: Alzheimer Disease; Antioxidants; Drugs, Chinese Herbal; Free Radical Scavengers; Free Radicals; Humans; Monoamine Oxidase Inhibitors; Neurons; Parkinson Disease; Piperazines; Psychotropic Drugs; Selegiline; Thiophenes; Vitamins | 1998 |
3 other study(ies) available for tenilsetam and Alzheimer Disease
| Article | Year |
|---|---|
Investigation Into the Effects of Tenilsetam on Markers of Neuroinflammation in GFAP-IL6 Mice.
Topics: Alzheimer Disease; Animals; Anti-Inflammatory Agents, Non-Steroidal; Biomarkers; Cerebellum; Chronic Disease; Hippocampus; Humans; Inflammation; Interleukin-6; Mice, Inbred C57BL; Mice, Transgenic; Microglia; Piperazines; Pyruvaldehyde; Thiophenes; Tissue Distribution; Tumor Necrosis Factor-alpha | 2018 |
The cognition-enhancing drug tenilsetam is an inhibitor of protein crosslinking by advanced glycosylation.
Topics: Aging; Alzheimer Disease; Cognition Disorders; Glycation End Products, Advanced; Glycosylation; Humans; Macromolecular Substances; Nerve Tissue Proteins; Piperazines; Psychotropic Drugs; Thiophenes | 1994 |
Influence of advanced glycation end-products and AGE-inhibitors on nucleation-dependent polymerization of beta-amyloid peptide.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Benzothiazoles; Carnosine; Cognition; Cross-Linking Reagents; Fructose; Glycation End Products, Advanced; Guanidines; Humans; Memory; Neuropeptide Y; Particle Size; Peptide Fragments; Piperazines; Protein Structure, Secondary; Solubility; Temperature; Thiazoles; Thiophenes | 1997 |